EntreMed to acquire Miikana - acquisition strengthens oncology pipeline.: An article from: BIOTECH Patent News
from $5.95
EntreMed and Affymax form tissue factor pathway inhibitor peptides collaboration.: An article from: BIOTECH Patent News
More results from Amazon »